Overview

Study of Escitalopram in Adult Patients With Major Depressive Disorder

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy, safety, and pharmacoeconomics of escitalopram and an active comparator in patients with major depressive disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Citalopram
Dexetimide